Abstract
This is a review of studies in man with various compounds which inhibit enzymatic reactions involved in the synthesis and metabolism of NE. Emphasis is given to techniques for measurement of enzyme inhibition in man and the relationship between inhibition of a given enzyme and concurrent pharmacologic effects. Such a relationship seems established with the MAO inhibitors, is lacking in the case of decarboxylase inhibitors though one of these (α-methyl-dopa) is a useful drug, and seems likely with tyrosine hydroxylase inhibitors. Data are presented indicating that significant inhibition of catecholamine synthesis in man has been achieved with a compound of the latter type, α-methyl-p-tyrosine.
PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.